Combination of baseline and first-week neutrophil-to-lymphocyte ratio predicts overall survival in advanced renal cell carcinoma treated with first-line combination immunotherapy

International Journal of Clinical Oncology · Published 2026-07-11 · DOI 10.1007/s10147-026-03115-x

Free full text

Authors (15)

Takeshi Sasaki, Shinichiro Higashi, Kouhei Nishikawa, Koji Iinuma, Keita Nakane, Tomoki Taniguchi, Yuta Sano, Aika Matsuyama, Kaori Ozawa, Kosuke Tochigi, Masataka Tamura, Yasuaki Kubota, Shusuke Akamatsu, Takuya Koie, Takahiro Inoue

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Sasaki, T., Higashi, S., Nishikawa, K., et al. (2026). Combination of baseline and first-week neutrophil-to-lymphocyte ratio predicts overall survival in advanced renal cell carcinoma treated with first-line combination immunotherapy. International Journal of Clinical Oncology. https://doi.org/10.1007/s10147-026-03115-x

Related articles

• Pretreatment serum vitamin D levels predict the therapeutic efficacy of atezolizumab plus bevacizumab therapy in advanced hepatocellular carcinoma: a multicenter analysis · International Journal of Clinical Oncology · 2026 · Same journal
• Sex differences in the prognostic value of body mass index after curative nephrectomy for high-risk renal cell carcinoma: a multicenter cohort study · International Journal of Clinical Oncology · 2026 · Same journal
• The role of surgical timing in survival of patients with spinal metastases · International Journal of Clinical Oncology · 2026 · Same journal
• Racial disparities in time to treatment initiation and survival outcomes in patients with vulvar cancer: a national cancer database analysis · International Journal of Clinical Oncology · 2026 · Same journal
• Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer · International Journal of Clinical Oncology · 2026 · Same journal
• Clinical utility of comprehensive genomic profiling in thoracic malignancies beyond conventional gene testing · International Journal of Clinical Oncology · 2026 · Same journal
• Positive peritoneal cytology and recurrence patterns in endometrial cancer according to postoperative recurrence risk classification: a retrospective cohort study · International Journal of Clinical Oncology · 2026 · Same journal
• Efficacy of anti-GD2 antibody immunotherapy with filgrastim and teceleukin versus standard treatment with sargramostim, aldesleukin and isotretinoin in children with high-risk neuroblastoma · International Journal of Clinical Oncology · 2026 · Same journal
• Prognostic significance of predicted skeletal muscle index after curative-intent resection for non-small cell lung cancer · International Journal of Clinical Oncology · 2026 · Same journal
• RNF125 mediates the anti-breast cancer activity of betulinic acid through ubiquitin-dependent degradation of MYH9 · International Journal of Clinical Oncology · 2026 · Same journal